2021
DOI: 10.3389/fcell.2021.644986
|View full text |Cite
|
Sign up to set email alerts
|

Membrane Transport Proteins in Osteoclasts: The Ins and Outs

Abstract: During bone resorption, the osteoclast must sustain an extraordinarily low pH environment, withstand immense ionic pressures, and coordinate nutrient and waste exchange across its membrane to sustain its unique structural and functional polarity. To achieve this, osteoclasts are equipped with an elaborate set of membrane transport proteins (pumps, transporters and channels) that serve as molecular ‘gatekeepers’ to regulate the bilateral exchange of ions, amino acids, metabolites and macromolecules across the r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
23
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 29 publications
(23 citation statements)
references
References 228 publications
(250 reference statements)
0
23
0
Order By: Relevance
“…Further matrix collagen (63) and extracellular acidosis (64) are also important factors driving fusion and resorption by osteoclasts at the bone surface. Although not critical to osteoclast survival, the capacity for osteoclasts to resorb bone via their specialized ruffled border is highly dependent on the process of membrane trafficking (65). Recent work has highlighted multiple novel osteoclastspecific therapeutic targets, which will inhibit their function rather than formation or survival, thereby negating possible feedback mechanisms such as those driving denosumab rebound bone loss, as discussed later.…”
Section: Maintenance and Functionmentioning
confidence: 99%
“…Further matrix collagen (63) and extracellular acidosis (64) are also important factors driving fusion and resorption by osteoclasts at the bone surface. Although not critical to osteoclast survival, the capacity for osteoclasts to resorb bone via their specialized ruffled border is highly dependent on the process of membrane trafficking (65). Recent work has highlighted multiple novel osteoclastspecific therapeutic targets, which will inhibit their function rather than formation or survival, thereby negating possible feedback mechanisms such as those driving denosumab rebound bone loss, as discussed later.…”
Section: Maintenance and Functionmentioning
confidence: 99%
“…These circumstances can modify the bone matrix by osteoclast reprogramming. These cells may produce an exacerbated number of osteolytic proteins such as H + -ATPases, V-ATPase, and chloride channel 7 [ 41 , 42 ]. This process alters natural homeostasis triggering acidification processes able to alter bone turnover [ 23 ].…”
Section: Pathogenesismentioning
confidence: 99%
“…Thus far, the molecular anatomy of SLs has largely been gleamed from unsystematic studies of genetically-modified mice with high bone mass phenotypes and incidental genetic findings arising from patients with rare sclerosing bone dysplasia (Sobacchi et al, 2013). While these studies have greatly advanced our understanding of the molecules involved in SL biogenesis (Lacombe et al, 2013) as well as the participants and downstream effectors regulating SL trafficking (Ng et al, 2019), surprisingly little is known about the nature and number of transport systems that reside on SLs and orchestrate the exchange of small molecules, such as ions, amino acids and sugars across its membrane (Ribet et al, 2021). In addition, how SLs are organized in osteoclasts, both spatially and temporally, is unclear.…”
Section: Introductionmentioning
confidence: 99%